Histological lipid grading together with Oil Red O staining results, and measurement of triglyceride levels suggest that altering Chi3L1 protein function with specific targeted agents to Chi3L1 may be beneficial in reducing hepatic steatosis as well. This evidence concerns the gene CHI3L1 and fatty liver disease.